Market News / Story
Retension Pharmaceuticals, Inc. Prices $45M Upsized IPO at $12/Share
·
Retension Pharmaceuticals priced an upsized IPO of 3.75M shares at $12, for gross proceeds of $45.0M. Shares are expected to begin trading Oct. 9 on Nasdaq under RTSN; closing is expected Oct. 13, subject to customary conditions. Material Details #DetailAI Analyst View1IPO priced at $12 for 3.75M sharesSets initial valuation and float; pricing clarity drives first-day trading.2Gross proceeds expected $45.0MDetermines runway to fund Phase 2b completion and Phase 3…